Results 71 to 80 of about 29,769 (281)
Outcome of patients with local recurrent gynecologic malignancies after resection combined with intraoperative electron radiation therapy (IOERT) [PDF]
Background: Treatment of recurrent gynecologic cancer is a challenging issue. Aim of the study was to investigate clinical features and outcomes of patients with recurrent gynecologic malignancies who underwent resection including IOERT (intraoperative ...
Arians, Nathalie +6 more
core +2 more sources
Risk of Cancer With Hormone Replacement Therapy: A Narrative Review
ABSTRACT Hormone replacement therapy (HRT) remains the cornerstone of menopausal symptom management, effectively alleviating vasomotor symptoms and genitourinary syndrome, whilst mitigating long‐term risks such as osteoporosis. However, despite an increasing body of evidence on the relative safety of HRT, earlier studies that demonstrated an increased ...
Gabriella Yongue +3 more
wiley +1 more source
Introduction Our objective was to investigate the trajectories of anxiety, depression, emotional and social functioning in women with newly diagnosed vulvar cancer from the time of diagnosis to 12 months after treatment.
Diana Zach +7 more
doaj +1 more source
Current Techniques for Detecting Sentinel Lymph Nodes in Vulvar Cancer
Introduction. Vulvar cancer belongs to the group of rare neoplasms and accounts for about 4% of all gynecological malignant tumours. One of the important barriers to the spread of the tumour cell population is the lymph nodes.
Sh. Kh. Gantsev +2 more
doaj +1 more source
Surgical technique for video endoscopic inguinal lymphadenectomy in vulvar cancer [PDF]
Introduction: Inguinal lymph node involvement is an important prognostic factor in patients with vulvar cancer. Inguinal lymph node dissection allows for staging and treatment of inguinal node disease but causes morbidity and is associated with ...
Calpe Gómez, Enrique +4 more
core +2 more sources
ABSTRACT There have only been a limited number of case reports that have described vulval lichen sclerosus in patients receiving immune checkpoint inhibitor (ICI) therapy. We describe 11 cases of vulval lichen sclerosus in patients with melanoma treated with ICIs, and in nine of these cases, the lichen sclerosus symptoms began after ICI commencement ...
Sophie Walter +9 more
wiley +1 more source
There is limited data regarding the use of immunotherapy for patients with vulvar squamous cell carcinoma and coexisting autoimmune disease. Cemiplimab is a PD-1 inhibitor approved for use in patients with locally advanced and metastatic cutaneous ...
Elizabeth G. Thayer +6 more
doaj +1 more source
Added value of intraoperative real-time imaging in searches for difficult-to-locate sentinel nodes. [PDF]
Localization of sentinel lymph nodes can be challenging if they are in difficult anatomic locations or near high radiotracer activity The purpose of this study was to assess the value of intraoperative real-time imaging using a portable gamma-camera in ...
Caparrós, Xavier +8 more
core +1 more source
ABSTRACT Background Vulval Lichen Sclerosus (VLS) is a chronic inflammatory condition requiring lifelong management to prevent severe complications including malignancy. A shared care model between general practitioners (GPs) and public non‐GP specialists (dermatologist or gynaecologist) for patients with stable LS would alleviate the demand on public ...
Arav Kannen +3 more
wiley +1 more source
Vulvar cancer incidence and net survival in Sweden 1960 to 2019: A population‐based national study
Introduction Vulvar cancer is a rare gynecological cancer affecting mostly older women. The aim of this population‐based study was to investigate the incidence and net survival of vulvar cancer in Swedish women from 1960 to 2019.
Louise Moberg +4 more
doaj +1 more source

